High-intensity focused ultrasound (HIFU) treatment has recently emerged as an alternative treatment for glaucoma1 and has also been used in response to the increasing demand for noninvasive procedures for skin lifting and tightening by direct application of an ultrasonographic probe to the skin.2,3 In the periorbital region, the HIFU probe is put onto the skin, and shots are applied (with energy between 0.2 and 2.0 J and 4 to 7 MHz), with a safe distance of at least 2 mm from the orbital margins according to the manufacturers’ instructions. Treatments involving HIFU were approved by the US Food and Drug Administration in 2009 for use in browlifting, and it is currently being used for facial rejuvenation, lifting, tightening, and body contouring, which are considered off-label uses.2 It is well known that traumatic cataract can occur after 11% of closed globe injuries and are attributable to the application of mechanical, irradiative, electrical, or chemical insults.4
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Strauss RW, Bolz M. Lens Opacity Following High-Intensity Focused Ultrasound. JAMA Ophthalmol. 2020;138(2):215–216. doi:10.1001/jamaophthalmol.2019.4963
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: